Clinical Trials Directory

Trials / Conditions / Advanced Esophageal Carcinoma

Advanced Esophageal Carcinoma

7 registered clinical trials studyying Advanced Esophageal Carcinoma3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apa
NCT06745193
Peking UniversityPhase 2
RecruitingOlanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, He
NCT05705492
OHSU Knight Cancer InstitutePhase 2
RecruitingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
Mayo ClinicPhase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or C
NCT04491942
National Cancer Institute (NCI)Phase 1
CompletedFOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma
NCT02023593
Yuhong LiPhase 2
UnknownmFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus
NCT01486992
Peking UniversityPhase 2
UnknownmFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment
NCT01044420
Peking UniversityPhase 2